A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy

2010 ◽  
Vol 21 (4) ◽  
pp. 433-438 ◽  
Author(s):  
Tomasz M. Beer ◽  
Charles Ryan ◽  
Joshi Alumkal ◽  
Christopher W. Ryan ◽  
Janine Sun ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Transdermal Estradiol ◽  
Docetaxel Chemotherapy

scholarly journals Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer

2009 ◽  
Vol 15 (22) ◽  
pp. 7099-7105 ◽  
Author(s):  
Mary-Ellen Taplin ◽  
Meredith M. Regan ◽  
Yoo-Joung Ko ◽  
Glenn J. Bubley ◽  
Stephen E. Duggan ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Castration Resistant Prostate Cancer ◽  
Synthesis Inhibition ◽  
Androgen Synthesis ◽  
Castration Resistant

Abstract A221: A phase II study of SB939 in patients with recurrent or metastatic castration resistant prostate cancer (CRPC).

2011 ◽  
Author(s):  
Bernhard J. Eigl ◽  
Scott North ◽  
Nevin Murray ◽  
Daniel YC Heng ◽  
Eric Winquist ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant
Sign in / Sign up

Export Citation Format

Share Document